stock-detail (DVAX)

Oncology Corporate Profile

Company Description

This company does not have any commercial products

This company does not have any pipeline products

Recent News Headlines

4/24/2017 06:17 pm

4/24/2017 06:17 pm

4/24/2017 06:17 pm

4/24/2017 06:17 pm

4/7/2017 12:17 pm

4/7/2017 12:17 pm

4/7/2017 12:17 pm

4/7/2017 12:17 pm

4/7/2017 12:17 pm

4/7/2017 06:17 am

4/7/2017 06:17 am

4/7/2017 06:17 am

4/7/2017 06:17 am

4/7/2017 06:17 am

Dynavax Announces FDA Advisory Committee Meeting to Review HEPLISAV-B

4/3/2017 10:00 am

[Marketwired] - Dynavax Technologies Corporation announced today that the U.S. Food and Drug Administration has informed the company that the Vaccines and Related Biological Products Advisory Committee will review HEPLISAV-B™......

Dynavax Announces Upcoming Data Presentations for Three TLR9 Agonist Programs at the 2017 American Association for Cancer Research Annual Meeting

3/20/2017 10:00 am

[Marketwired] - Dynavax Technologies Corporation announced today that it will be presenting data on three programs based on stimulation of the immune response using Toll-Like Receptor 9 agonists at the 2017 American Association ...